-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 29, 2021, the State Food and Drug Administration held a TCM quality and safety supervision work meeting to comprehensively summarize the quality and safety supervision of traditional Chinese medicines in 2021, analyze the current regulatory situation and problems in depth, study and deploy key tasks in 2022, and continue to strengthen the quality and safety supervision of traditional Chinese medicines
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
The meeting pointed out that in 2021, the State Food and Drug Administration will thoroughly implement the decisions and deployments of the Party Central Committee and the State Council on promoting the inheritance, innovation and development of traditional Chinese medicine , strictly implement the "four most stringent" requirements, and strengthen the quality and safety supervision of traditional Chinese medicine used in the prevention and control of the new crown pneumonia epidemic.
Effectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Effectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Zhao Junning fully affirmed the achievements of the quality and safety supervision of Chinese medicines after the market in 2021
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
Zhao Junning requested that the drug regulatory authorities must adhere to the guidance of Xi Jinping’s new era of socialism with Chinese characteristics as a guide, and do a solid job of monitoring the quality and safety of traditional Chinese medicine in 2022
.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
The meeting was held by video
.
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
.
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
On December 29, 2021, the State Food and Drug Administration held a TCM quality and safety supervision work meeting to comprehensively summarize the quality and safety supervision of traditional Chinese medicines in 2021, analyze the current regulatory situation and problems in depth, study and deploy key tasks in 2022, and continue to strengthen the quality and safety supervision of traditional Chinese medicines
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
The meeting pointed out that in 2021, the State Food and Drug Administration will thoroughly implement the decisions and deployments of the Party Central Committee and the State Council on promoting the inheritance, innovation and development of traditional Chinese medicine , strictly implement the "four most stringent" requirements, and strengthen the quality and safety supervision of traditional Chinese medicine used in the prevention and control of the new crown pneumonia epidemic.
Effectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Effectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Zhao Junning fully affirmed the achievements of the quality and safety supervision of Chinese medicines after the market in 2021
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
Zhao Junning requested that the drug regulatory authorities must adhere to the guidance of Xi Jinping’s new era of socialism with Chinese characteristics as a guide, and do a solid job of monitoring the quality and safety of traditional Chinese medicine in 2022
.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
The meeting was held by video
.
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
.
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
On December 29, 2021, the State Food and Drug Administration held a TCM quality and safety supervision work meeting to comprehensively summarize the quality and safety supervision of traditional Chinese medicines in 2021, analyze the current regulatory situation and problems in depth, study and deploy key tasks in 2022, and continue to strengthen the quality and safety supervision of traditional Chinese medicines
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
.
Zhao Junning, member of the Party Leadership Group and Deputy Director of the State Food and Drug Administration, attended the meeting and delivered a speech
.
The meeting pointed out that in 2021, the State Food and Drug Administration will thoroughly implement the decisions and deployments of the Party Central Committee and the State Council on promoting the inheritance, innovation and development of traditional Chinese medicine , strictly implement the "four most stringent" requirements, and strengthen the quality and safety supervision of traditional Chinese medicine used in the prevention and control of the new crown pneumonia epidemic.
Effectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Pharmaceutical medicine pharmaceutical legislation and regulations and regulations business enterprise enterpriseEffectively guarantee quality and supply
.
And constantly improve the supervision of TCM regulatory system building, and introduce traditional Chinese medicine production enterprise policy to take advantage of buying fresh cut herbs, and guide the development of Chinese herbal medicine standardization, accelerate the "Good Agricultural Practice" (GAP) revision
.
Promote the special rectification of traditional Chinese medicine decoction pieces and special inspections of traditional Chinese medicine production to achieve practical results, organize targeted unannounced inspections, and strengthen random inspections and adverse reaction monitoring
.
The drug regulatory authority strictly implements territorial regulatory responsibilities, severely investigates and handles cases of violations of laws and regulations in the production of traditional Chinese medicine, urges enterprises to effectively implement the main responsibility, promotes the successful completion of various objectives and tasks of quality and safety supervision of traditional Chinese medicine, and promotes the continuous improvement of the overall quality of traditional Chinese medicine
.
Zhao Junning fully affirmed the achievements of the quality and safety supervision of Chinese medicines after the market in 2021
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
.
He emphasized that it is necessary to accurately grasp the current new situation, new tasks and new challenges faced by the quality and safety supervision of traditional Chinese medicine, systematically think, make overall plans, be brave to innovate, and dare to take responsibility, and orderly advance the reform of the traditional Chinese medicine regulatory system, strengthen the quality and safety supervision of traditional Chinese medicine, and promote traditional Chinese medicine.
High-quality development
.
Zhao Junning requested that the drug regulatory authorities must adhere to the guidance of Xi Jinping’s new era of socialism with Chinese characteristics as a guide, and do a solid job of monitoring the quality and safety of traditional Chinese medicine in 2022
.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
Chinese Medicine Chinese Medicine Chinese Medicine.
First, we must continue to strengthen the supervision of Chinese herbal medicines and proprietary Chinese medicines for the prevention and control of the new crown pneumonia epidemic, provide technical guidance and other services, support traditional Chinese medicine to continue to play an important role in normalized epidemic prevention and control, and ensure the overall situation of epidemic prevention and control
.
Second, we must accelerate the issuance and implementation of the newly revised GAP, orderly promote the procurement of traditional Chinese medicine decoction pieces to produce Chinese medicinal materials while they are fresh, guide and promote the standardized development of Chinese medicinal materials, and promote the quality of Chinese medicine from the source
.
Third, we must effectively supervise traditional Chinese medicine formula particles, strictly enforce product and enterprise access, adhere to the scientific nature of traditional Chinese medicine formula particles, strictly control complete production capacity, and must not relax requirements in disguise by sharing workshops within the group, and carry out full coverage inspections of production enterprises.
, Sampling inspections of all varieties, and urge enterprises to ensure product quality and safety
.
Fourth, we must focus on strengthening the quality supervision of Chinese herbal medicines and proprietary Chinese medicines, continue to organize special inspections and cause-related inspections, strengthen random inspections and adverse reaction monitoring, strengthen supervision of all links of production, circulation, and use, strengthen the organic connection of inspections and inspections, and severely crack down on violations of laws and regulations
.
Fifth, we must comprehensively improve the ability and level of Chinese medicine supervision, actively promote the construction of a "national chess game", vigorously promote the scientific research of Chinese medicine supervision, actively play the role of "smart supervision", and continuously meet the needs of the quality and safety supervision of Chinese medicine in the new era, and effectively protect the people's use of medicines Safe and effective
.
The meeting was held by video
.
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
Medicine, medicine, medicine .
Representatives from 7 provinces (regions) of the Food and Drug Administration of Anhui, Jiangxi, Gansu, Shandong, Xinjiang, Jiangsu and Guangdong exchanged speeches on special rectification of Chinese herbal medicines, special inspections of Chinese medicine production, and unannounced inspections of Chinese medicines
.
Relevant persons in charge of relevant departments and bureaus of the State Food and Drug Administration and directly affiliated units, as well as relevant persons in charge of the quality and safety supervision of traditional Chinese medicine, relevant departments, and drug inspection agencies of the provinces (autonomous regions and municipalities) and Xinjiang Production and Construction Corps Drug Administration, attended the meeting
.
